{"data":{"id":"us/21-cfr-203.10","jurisdiction":"us","citation":"21 CFR 203.10","heading":"Restrictions on reimportation.","body":"No prescription drug or drug composed wholly or partly of insulin that was manufactured in a State and exported from the United States may be reimported by anyone other than its manufacturer, except that FDA may grant permission to a person other than the manufacturer to reimport a prescription drug or insulin-containing drug if it determines that such reimportation is required for emergency medical care.","path":["Title 21—Food and Drugs","CHAPTER I—FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES","SUBCHAPTER C—DRUGS: GENERAL","PART 203—PRESCRIPTION DRUG MARKETING","Subpart B—Reimportation"],"source_url":"https://www.ecfr.gov/api/versioner/v1/full/2026-08-25/title-21.xml","current_through":"2026-08-25","vintage":"","retrieved_at":"2026-08-27T02:24:47Z","sha256":"b6acb35aaf997e5d19ce363b8cecc74257e174e0db281ad38e544933dbe7f9ef","source_id":"us-cfr","stale":true,"prev":"us/21-cfr-203.3","next":"us/21-cfr-203.11"},"notice":"GroundRules: Original legal text. Not legal advice."}